Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
JCO Oncol Pract ; 18(12): e1971-e1976, 2022 12.
Artigo em Inglês | MEDLINE | ID: mdl-36343305

RESUMO

PURPOSE: Continued smoking after the diagnosis of cancer can markedly worsen oncology treatment side effects, cancer outcomes, cancer mortality, and all-cause mortality. Conversely, mounting evidence demonstrates that smoking cessation by patients with cancer improves outcomes. A cancer diagnosis often serves as a teachable moment, characterized by high motivation to quit. However, too few patients with cancer who smoke are offered evidence-based smoking cessation treatment, and too few engage in such treatment. METHODS AND MATERIALS: The National Cancer Institute commissioned Tobacco Control Monograph 23, Treating Smoking in Cancer Patients: An Essential Component of Cancer Care, to review and synthesize the evidence that clarifies the need to intervene with smoking in cancer care. RESULTS: Although many patients with newly diagnosed cancer who smoke make quit attempts, many of these are unsuccessful, and among those who successfully quit, relapse is common. Indeed, an estimated 12.2% of adults ever diagnosed with cancer reported they currently smoked (National Health Interview Survey, 2020). Patients with cancer who smoke are likely to benefit from smoking cessation treatments, including counseling and US Food and Drug Administration-approved medications, and there are many effective strategies to increase delivery of smoking cessation treatment in cancer care settings. CONCLUSION: Smoking cessation is among the most effective treatment options for improving the likelihood of survival, quality of life, and overall health of patients with cancer who smoke. It is important for cancer care clinicians and patients to realize that it is never too late to quit smoking and that there are clear benefits to doing so, regardless of cancer type.


Assuntos
Neoplasias , Abandono do Hábito de Fumar , Adulto , Estados Unidos/epidemiologia , Humanos , National Cancer Institute (U.S.) , Qualidade de Vida , Controle do Tabagismo , Abandono do Hábito de Fumar/psicologia , Neoplasias/complicações , Neoplasias/epidemiologia , Neoplasias/terapia , Fumar/epidemiologia , Fumar/terapia
2.
J Natl Cancer Inst ; 114(2): 179-186, 2022 Feb 07.
Artigo em Inglês | MEDLINE | ID: mdl-34240206

RESUMO

It is estimated that behaviors such as poor diet, alcohol consumption, tobacco use, sedentary behavior, and excessive ultraviolet exposure account for nearly one-half of all cancer morbidity and mortality. Accordingly, the behavioral, social, and communication sciences have been important contributors to cancer prevention and control research, with methodological advances and implementation science helping to produce optimally effective interventions. To sustain these contributions, it is vital to adapt to the contemporary context. Efforts must consider ancillary effects of the 2019 coronavirus disease pandemic, profound changes in the information environment and public understanding of and trust in science, renewed attention to structural racism and social determinants of health, and the rapidly increasing population of cancer survivors. Within this context, it is essential to accelerate reductions in tobacco use across all population subgroups; consider new models of energy balance (diet, physical activity, sedentary behavior); increase awareness of alcohol as a risk factor for cancer; and identify better communication practices in the context of cancer-related decisions such as screening and genetic testing. Successful integration of behavioral research and cancer prevention depends on working globally and seamlessly across disciplines, taking a multilevel approach where possible. Methodological and analytic approaches should be emphasized in research training programs and should use new and underused data sources and technologies. As the leadership core of the National Cancer Institute's Behavioral Research Program, we reflect on these challenges and opportunities and consider implications for the next phase of behavioral research in cancer prevention and control.


Assuntos
Pesquisa Comportamental , Neoplasias , Consumo de Bebidas Alcoólicas/efeitos adversos , Consumo de Bebidas Alcoólicas/epidemiologia , Atenção à Saúde , Dieta , Exercício Físico , Humanos , Neoplasias/epidemiologia , Neoplasias/prevenção & controle
3.
Am J Prev Med ; 60(3 Suppl 2): S172-S184, 2021 03.
Artigo em Inglês | MEDLINE | ID: mdl-33663705

RESUMO

The rapid growth of smartphone ownership and broadband access has created new opportunities to reach smokers with cessation information and support using digital technologies. These technologies can both complement and be integrated with traditional support modalities such as telephone quitlines and 1-on-1 clinical cessation counseling. The National Cancer Institute's Smokefree.gov Initiative provides free, evidence-based cessation support to the public through a multimodal suite of digital interventions, including several mobile-optimized websites, text messaging programs, and 2 mobile applications. In addition to digital resources directed at the general population, the Smokefree.gov Initiative includes population-specific resources targeted to adolescents, women, military veterans, Spanish speakers, older adults, and other populations. This paper describes the reach and use of the Smokefree.gov Initiative's resources over a 5-year period between 2014 and 2018, including how users interact with the program's digital content in ways that facilitate engagement with live counseling support. Use of Smokefree.gov Initiative resources has grown steadily over time; in 2018 alone, approximately 7-8 million people accessed Smokefree.gov Initiative web- and mobile-based resources. Smokefree.gov Initiative utilization data show that people take advantage of the full range of technology tools and options offered as part of the Smokefree.gov Initiative's multiplatform intervention. The Smokefree.gov Initiative experience suggests that offering different, complementary technology options to meet the needs and preferences of smokers has the potential to meaningfully expand the reach of cessation treatment.


Assuntos
Tecnologia Digital , National Cancer Institute (U.S.) , Abandono do Hábito de Fumar , Adolescente , Idoso , Feminino , Humanos , Fumantes , Abandono do Hábito de Fumar/métodos , Nicotiana , Estados Unidos
4.
Acta Obstet Gynecol Scand ; 89(4): 442-453, 2010.
Artigo em Inglês | MEDLINE | ID: mdl-20235895

RESUMO

Although the prevalence of tobacco use is decreasing in many high-income countries, it is increasing in many low- and middle-income countries. The health and economic burden of increasing tobacco use and dependence is predictable and will have devastating effects in countries with limited resources, particularly for vulnerable populations such as pregnant women. We sought to review effective tobacco prevention and intervention strategies for decreasing tobacco use and secondhand smoke exposure before and during pregnancy in high-, middle-, and low-income countries. We reviewed several types of interventions, including population-level efforts (increasing tobacco prices, implementing tobacco control policies), community interventions, clinical interventions, and pharmacological treatments. A second purpose of this report is to present findings of an international expert working group that was convened to review the evidence and to establish research priorities in the following areas: (a) preventing the uptake and reducing tobacco use among girls and women of reproductive age; and (b) reducing tobacco use and secondhand smoke exposure among pregnant women. The working group considered the evidence on existing interventions in terms of burden of disease, intervention impact, intervention costs, feasibility of integration into existing services, uniqueness of the contribution, and overall feasibility. Finally, we present the working group's recommendations for intervention research priorities.


Assuntos
Países em Desenvolvimento , Exposição Materna/prevenção & controle , Saúde Pública , Abandono do Hábito de Fumar/métodos , Prevenção do Hábito de Fumar , Poluição por Fumaça de Tabaco/prevenção & controle , Adolescente , Publicidade/legislação & jurisprudência , Terapia Comportamental , Pesquisa Biomédica , Feminino , Prioridades em Saúde , Humanos , Meios de Comunicação de Massa , Exposição Materna/efeitos adversos , Nicotina/uso terapêutico , Agonistas Nicotínicos/uso terapêutico , Gravidez , Embalagem de Produtos , Prevenção Secundária , Fumar/efeitos adversos , Fumar/economia , Fumar/epidemiologia , Impostos , Poluição por Fumaça de Tabaco/efeitos adversos
5.
Dev Cogn Neurosci ; 32: 4-7, 2018 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-29051027

RESUMO

Adolescence is a time of dramatic changes in brain structure and function, and the adolescent brain is highly susceptible to being altered by experiences like substance use. However, there is much we have yet to learn about how these experiences influence brain development, how they promote or interfere with later health outcomes, or even what healthy brain development looks like. A large longitudinal study beginning in early adolescence could help us understand the normal variability in adolescent brain and cognitive development and tease apart the many factors that influence it. Recent advances in neuroimaging, informatics, and genetics technologies have made it feasible to conduct a study of sufficient size and scope to answer many outstanding questions. At the same time, several Institutes across the NIH recognized the value of collaborating in such a project because of its ability to address the role of biological, environmental, and behavioral factors like gender, pubertal hormones, sports participation, and social/economic disparities on brain development as well as their association with the emergence and progression of substance use and mental illness including suicide risk. Thus, the Adolescent Brain Cognitive Development study was created to answer the most pressing public health questions of our day.


Assuntos
Desenvolvimento do Adolescente/fisiologia , Encéfalo/crescimento & desenvolvimento , Cognição/fisiologia , National Institutes of Health (U.S.)/normas , Neuroimagem/métodos , Transtornos Relacionados ao Uso de Substâncias/diagnóstico , Adolescente , Feminino , Humanos , Estudos Longitudinais , Transtornos Relacionados ao Uso de Substâncias/patologia , Estados Unidos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA